Literature DB >> 8953566

Coenzyme Q, peroxidation and cytochrome oxidase features after parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine.

M Battino1, G P Littarru, A Gorini, R F Villa.   

Abstract

The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration on respiratory chain features were studied in synaptic and non-synaptic mitochondrial populations from cerebral cortex and hippocampus of Macaca Fascicularis (Cynomolgus monkey). Enzymatic activity, cytochrome a + a3 content and turnover numbers of Complex IV, contents of Coenzyme Q10, of hydroperoxides and membrane fluidity were assessed in non-synaptic "perikaryal" and intra-synaptic "light" and "heavy" mitochondria isolated: (a) from the dopaminergic ascending terminal areas of cerebral cortex of monkeys treated p.o. with dihydroergocriptine at the dose of 2, 6 or 20 mg/kg/day for 52 weeks; (b) from the dopaminergic terminal areas of hippocampus of monkeys treated p.o. with dihydroergocriptine at the dose of 12 mg/kg/day before and during the induction of a Parkinson's-like syndrome by MPTP administration (i.v., 0.3 mg/kg/day for 5 days). Dihydroergocriptine administration moderately increased both cytochrome oxidase activity and cytochrome a + a3 content in "light" intra-synaptic mitochondria and hydroperoxides/CoQ10 ratio in all the types of mitochondria, as a consequence of the enhanced energy metabolism. The Parkinson's-like syndrome by MPTP changed the biochemical investigated parameters, affecting both directly the respiratory chain structures, i.e. by respiratory chain complexes inhibition and indirectly, i.e. by free radical mediated damages. MPTP administration negatively influenced Complex IV activity and Turnover Number of intra-synaptic mitochondria, without affecting the total cytochrome a + a3 amount. In all types of mitochondria and particularly on the "light" intra-synaptic ones, MPTP-induced lesion enhanced hydroperoxides/Coenzyme Q10 molar ratio due to the fall in Coenzyme Q10 levels and the concomitant increase in hydroperoxides. Dihydroergocriptine treatment appeared to be effective in MPTP-treated animals in improving those mitochondrial features that probably suffered free radical insults.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8953566     DOI: 10.1007/bf02533098

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  52 in total

1.  Mitochondrial function in Parkinson's disease.

Authors:  L A Bindoff; M Birch-Machin; N E Cartlidge; W D Parker; D M Turnbull
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

2.  Oxidation and reduction of soluble cytochrome c by membrane-bound oxidase and reductase systems.

Authors:  L Smith; H C Davies; M Nava
Journal:  J Biol Chem       Date:  1974-05-10       Impact factor: 5.157

Review 3.  Lipid fluidity and membrane protein dynamics.

Authors:  G Lenaz
Journal:  Biosci Rep       Date:  1987-11       Impact factor: 3.840

4.  Microviscosity parameters and protein mobility in biological membranes.

Authors:  M Shinitzky; M Inbar
Journal:  Biochim Biophys Acta       Date:  1976-04-16

5.  MPTP, MPP+ and mitochondrial function.

Authors:  W J Nicklas; S K Youngster; M V Kindt; R E Heikkila
Journal:  Life Sci       Date:  1987-02-23       Impact factor: 5.037

6.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

Authors:  K Chiba; A Trevor; N Castagnoli
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

7.  Peroxidative extent and coenzyme Q levels in the rat: influence of physical training and dietary fats.

Authors:  J L Quiles; J R Huertas; M Mañas; M Battino; M Cassinello; G P Littarru; G Lenaz; F J Mataix
Journal:  Mol Aspects Med       Date:  1994

8.  Mitochondrial oxidative phosphorylation defects in Parkinson's disease.

Authors:  J M Shoffner; R L Watts; J L Juncos; A Torroni; D C Wallace
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

9.  Mitochondrial factors involved in Parkinson's disease by MPTP toxicity in Macaca fascicularis and drug effect.

Authors:  R F Villa; R Arnaboldi; B Ghigini; A Gorini
Journal:  Neurochem Res       Date:  1992-11       Impact factor: 3.996

10.  Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria.

Authors:  J F Turrens; A Boveris
Journal:  Biochem J       Date:  1980-11-01       Impact factor: 3.857

View more
  8 in total

1.  Differentiated effect of ageing on the enzymes of Krebs' cycle, electron transfer complexes and glutamate metabolism of non-synaptic and intra-synaptic mitochondria from cerebral cortex.

Authors:  R F Villa; A Gorini; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  2006-09-14       Impact factor: 3.575

2.  Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.

Authors:  G Gille; K Radad; H Reichmann; W-D Rausch
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

3.  Respiratory chain inhibition: one more feature to propose MPTP intoxication as a Leigh syndrome model.

Authors:  Barbara Da Costa; Elodie Dumon; Laurence Le Moigno; Sylvie Bodard; Pierre Castelnau; Thierry Letellier; Christophe Rocher
Journal:  J Bioenerg Biomembr       Date:  2016-10-27       Impact factor: 2.945

4.  Cerebral cortex synaptic heavy mitochondria may represent the oldest synaptic mitochondrial population: biochemical heterogeneity and effects of L-acetylcarnitine.

Authors:  M Battino; J L Quiles; J R Huertas; J F Mataix; R F Villa; A Gorini
Journal:  J Bioenerg Biomembr       Date:  2000-04       Impact factor: 2.945

5.  Coenzyme Q(10) is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria.

Authors:  D Haas; P Niklowitz; F Hörster; E R Baumgartner; C Prasad; R J Rodenburg; G F Hoffmann; T Menke; J G Okun
Journal:  J Inherit Metab Dis       Date:  2009-06-07       Impact factor: 4.982

6.  Functional proteomics of adenosine triphosphatase system in the rat striatum during aging.

Authors:  Roberto Federico Villa; Federica Ferrari; Antonella Gorini
Journal:  Neural Regen Res       Date:  2012-01-05       Impact factor: 5.135

Review 7.  Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson's disease.

Authors:  Yumin Wang; Shuang Wu; Qiang Li; Weihong Lang; Wenjing Li; Xiaodong Jiang; Zhirong Wan; Jichao Chen; Hongquan Wang
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

Review 8.  Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.

Authors:  Sushruta Koppula; Hemant Kumar; Sandeep Vasant More; Byung Wook Kim; In Su Kim; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2012-08-23       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.